Bactolife A/S
CVR 38879073 · Public limited company (A/S) · Active · Low risk
Bactolife A/S is a Public limited company (A/S), founded on , based in København Ø. The company is registered in the industry fremstilling af andre kemiske produkter i.a.n.. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 8 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 203.7m and a net result of DKK -74.0m.
Bankruptcy risk for Bactolife A/S
0.0 × the average (1.41%) · higher risk than 27% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 38879073
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (9 years)
- Address
- Rønnegade 8, 2.
2100 København Ø - Municipality
- København
- Industry
- Fremstilling af andre kemiske produkter i.a.n. (205900)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 1.1m
- Employees
- 1 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 91.8% |
| Current ratio | 1,289% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -36.0m | DKK -21.7m | DKK -16.8m |
| Net profit | DKK -74.0m | DKK -49.2m | DKK -45.6m |
| Equity | DKK 203.7m | DKK 162.5m | DKK 211.7m |
| Total assets | DKK 221.8m | DKK 175.9m | DKK 232.6m |
| Cash | DKK 187.4m | DKK 142.4m | – |
| Short-term debt | DKK 15.5m | DKK 11.9m | – |
| Avg. employees | 44 | 40 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 173 | ||
| 1 Jan 2024 – 31 Dec 2024 | 162 | ||
| 1 Jan 2023 – 31 Dec 2023 | 162 | ||
| 1 Jan 2022 – 31 Dec 2022 | 181 | ||
| 1 Jan 2021 – 31 Dec 2021 | 164 | ||
| 1 Jan 2020 – 31 Dec 2020 | 161 | ||
| 1 Jan 2019 – 31 Dec 2019 | 167 | ||
| 10 Aug 2017 – 31 Dec 2018 | 155 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Mads Aage Laustsen | ||
| CEO | Claus Sebastian Søderberg | ||
| Board | Jørgen Rugholm Jensen | Current | |
| Board | Mads Aage Laustsen | Current | |
| Board | Frank Julian Zachmann | Current | |
| Board | Rhonda Doyce Hoffman | Current | |
| Board | Sara Sande | Current | |
| Board | Sophia Andrea Helga Heyde | Current | |
| Board | Donna Margaret Parr | Current | |
| Board | Mads Aage Laustsen | ||
| Board | Andreas Hougaard Laustsen-Kiel | ||
| Board | Per Falholt | ||
| Board | David Carl Christian von Kauffmann | ||
| Board | Morten Jensen | ||
| Board | Morten Aleksandr Engel | ||
| Owner (5%) | SELFINVEST ApS | Current | |
| Owner (5%) | MR BIOINVEST ApS | Current | |
| Owner (20%) | Novo Holdings A/S | Current | |
| Owner (5%) | Danmarks Eksport- og Investeringsfond | Current | |
| Owner (20%) | ATHOS Biopharma GmbH | Current | |
| Owner (10%) | Gates Foundation | Current | |
| Owner (25%) | LAUSTSEN VENTURES ApS | ||
| Owner (25%) | MR BIOINVEST ApS | ||
| Owner (15%) | LILLE FREDERIKSLUND INVEST ApS | ||
| Owner (5%) | Sandra Wingaard Thrane | ||
| Owner (15%) | David Carl Christian von Kauffmann | ||
| Owner (10%) | David Carl Christian von Kauffmann | ||
| Owner (10%) | NOVOZYMES A/S | ||
| Owner (20%) | LAUSTSEN VENTURES ApS | ||
| Owner (15%) | LAUSTSEN VENTURES ApS | ||
| Owner (10%) | EEP CO-Investment Ltd. | ||
| Owner (10%) | SELFINVEST ApS | ||
| Owner (15%) | MR BIOINVEST ApS | ||
| Owner (25%) | Novo Holdings A/S | ||
| Owner (5%) | NOVOZYMES A/S | ||
| Owner (10%) | LILLE FREDERIKSLUND INVEST ApS | ||
| Owner (10%) | LAUSTSEN VENTURES ApS | ||
| Owner (5%) | EEP CO-Investment Ltd. | ||
| Owner (5%) | SELFINVEST ApS | ||
| Owner (5%) | MR BIOINVEST ApS | ||
| Owner (25%) | Novo Holdings A/S | ||
| Owner (5%) | NOVOZYMES A/S | ||
| Owner (5%) | LILLE FREDERIKSLUND INVEST ApS | ||
| Owner (5%) | LAUSTSEN VENTURES ApS | ||
| Owner (20%) | ATHOS Biopharma GmbH | ||
| Owner (5%) | Gates Foundation | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Founder | LAUSTSEN VENTURES ApS | Current |
The CEOs' other companies
Mads Aage Laustsen – 5 other companies
- AGC Biologics A/S Active
- BIONEER A/S Active
- MR BIOINVEST ApS Active
- SYNKLINO A/S Active
- VenomAid Diagnostics ApS Active
Claus Sebastian Søderberg – 5 other companies
- A/S POBRA Active
- J. S. INVEST ApS Active
- KF INVESTERING ApS Active
- KF Investeringsselskab ApS Active
- MAABJERG ENERGY CONCEPT A/S Opløst
Address history (3 moves)
| Rønnegade 8, 2., 2100 København Ø | |
| Lersø Parkallé 38, 2., 2100 København Ø | |
| c/o DTU Science Park, Diplomvej 381, 2800 Kongens Lyngby | |
| c/o Laustsen, Tinglevvej 3, 2820 Gentofte |
Former names
| Bactolife A/S | – now |
| Bactolife ApS | – |
Employees per year
Other companies at the same address
- NUEVOLUTION A/S Active
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about Bactolife A/S
Has Bactolife A/S gone bankrupt?
No, Bactolife A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Bactolife A/S?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of Bactolife A/S?
Bactolife A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Bactolife A/S founded?
Bactolife A/S was founded on 10 August 2017.
What is the equity of Bactolife A/S?
Equity was DKK 203.7m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.